Beyond the gut, ectopic expression of FXR has been found to induce an immunosuppressive milieu characterized by exhaustive CD8+ T-cells and the heightened infiltration of myeloid-derived suppressor cells in lung cancer [43]. The gene discussed is NR1H4; the disease is lung carcinoma.